Cirrhosis diagnosis and management is being discussed in various medical contexts, including its connection to metabolic dysfunction, diabetes, and other liver diseases. Different guidelines and reports are being published to address the diagnosis and management of cirrhosis and related conditions, such as cholestatic liver diseases and alcohol-associated liver diseases. The development of biomarkers, like CHI3L1, and expert guidance on managing complications, such as ascites and hyponatremia, are also being explored.